Claspin as a biomarker of human papillomavirus-related high grade lesions of uterine cervix

Sensitivity, Specificity, and Clinical Value of Human Papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for Cervical Cytology and HPV DNA Test

(2011) Maria Benevolo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multiple Functions of the S-Phase Checkpoint Mediator

(2010) Katsunori TANAKA   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Genomic instability and cancer: Lessons learned from human papillomaviruses

(2010) Nina Korzeniewski et al.   CANCER LETTERS

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

(2010) Ni Li et al.   INTERNATIONAL JOURNAL OF CANCER

Feasibility Study of a Human Papillomavirus E6 Oncoprotein Test for Diagnosis of Cervical Precancer and Cancer

(2010) Johannes Schweizer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Human Papillomavirus 16 E7 Oncoprotein Attenuates DNA Damage Checkpoint Control by Increasing the Proteolytic Turnover of Claspin

(2009) N. Spardy et al.   CANCER RESEARCH

p16INK4a immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis

(2009) I. Tsoumpou et al.   CANCER TREATMENT REVIEWS

Claspin inhibition leads to fragile site expression

(2009) Maria Luisa Focarelli et al.   GENES CHROMOSOMES & CANCER

How to evaluate emerging technologies in cervical cancer screening?

(2009) Marc Arbyn et al.   INTERNATIONAL JOURNAL OF CANCER

BD ProEx C: A Sensitive and Specific Marker of HPV-associated Squamous Lesions of the Cervix

(2008) Riem E. Badr et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Biomarkers in cervical precancer management: the new frontiers

(2008) Ashfaq M Khan et al.   Future Oncology

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial

(2008) Francesca Carozzi et al.   LANCET ONCOLOGY